Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial (Q45377444)
Jump to navigation
Jump to search
scientific article published on 5 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial |
scientific article published on 5 December 2013 |
Statements
1 reference
Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial (English)
1 reference
Henrik Watz
1 reference
Helen Barnacle
1 reference
Benjamin F Hartley
1 reference
Robert Chan
1 reference
5 December 2013
1 reference
1 reference
2
1 reference
1
1 reference
63-72
1 reference
Identifiers
1 reference
1 reference